Search
Last update: : 28.12.2024
The aim of this subproject S6 is to develop strategies for personalized, adaptive MR-guided dose escalation strategies for patients with non-small cell lung cancer. To achieve this,…
Last update: : 28.12.2024
Currently a weekly magnetic resonance imaging (MRI) of patients suffering from non-small-cell lung carcinoma (NSCLC) under radiotherapy (RT) is lacking. The primary objective utilizing the…
Last update: : 28.12.2024
This subproject aims at comparing the quality of treatment plans of the different treatment machines used at the participating centers. For each patient treated at one participating center,…
Last update: : 28.12.2024
The objective of subproject S3, carried out at the LMU University Hospital Munich, is to develop a novel workflow for dose accumulation using deep learning, tailored to lung cancer patients treated…
Last update: : 28.12.2024
Biometrical support for clinical PUMA Trial and PUMA II Trial (SP 1). Design and analysis of PUMA Trial (phase I feasibility study) and subsequently, based on the results of PUMA Trial, design…
Last update: : 28.12.2024
PUMA Trial The primary objective is to demonstrate the clinical feasibility of MR-guided online-adaptive radiotherapy of locally-advanced NSCLC (LA-NSCLC). The primary endpoint is a combined…
Last update: : 28.12.2024
A Feasibility Study within DKTK Image-guided adaptive radiotherapy (IGART) is the latest, technically most advanced treatment option in radiotherapy (RT). IGART monitors the anatomy of the day by…
Last update: : 28.12.2024
Especially the shuttle solution allows to include functional MRI or PET images to investigate e.g. biomarkers for early response monitoring during the course of therapy. We contribute to this area…
Last update: : 28.12.2024
Introduction Our research group mainly focuses on assessing the secondary radiation during proton and light ion beam therapy for cancer treatment. This is particularly relevant for pediatric and…